Author: Vikas Kumar
07 July 2022
Global bioreactor market is expected to register a CAGR of around 7% over the period of 2021-2027. A bioreactor is defined as a manufactured device or vessel in which a biological reaction is carried out and used to grow a variety of organisms such as yeast, bacteria, and animal cells in the appropriate environment. They form a sustainable environment for cell growth and product formation. Bioreactors are used in the pharmaceutical and biotechnology industries to produce vaccines, antibodies, or biological products. They are also used in industrial processes for culturing organisms under controlled conditions and producing medicines for the treatment of chronic diseases. The global bioreactor market is anticipated to witness an uptick with the continuous advancement in bioreactors. This along with the rapidly growing aging population across the globe is causing an increase in the number of patients having various chronic diseases such as cancer, diabetes, cardiovascular disease, and many more. For instance, as per Cancer.gov,in 2020, an estimated 1,806,590 new cases of cancer will be diagnosed in the United States and 606,520 people will die from the disease. Furthermore, the increasing need for innovative bioreactors that support modern, high-cell-density, and intensive processes that require high oxygen transfer and efficient carbon dioxide removal will positively influence product adoption in the pharmaceutical & biotechnology industry.
For a detailed analysis of the Global Bioreactor Market browse throughhttps://univdatos.com/report/bioreactors-market/
Based on material type, the market is classified into glass, stainless steel, and single-use. Amongst material types, the single-use category accounted for a significant share of the market owing to the various advantages offered by these types of bioreactors such as the reduced need for cleaning and sterilization, and reduced risk of cross-contamination.
Based on control type, the market is categorized into manual and automated. Among these, automated is expected to witness the highest CAGR during the forecast period. The growth of this segment can be attributed to the additional security assurance and reduce the operating costs of bioreactors.
Request for Sample of the report browse throughhttps://univdatos.com/get-a-free-sample-form-php/?product_id=22012
For a better understanding of the market adoption of the bioreactor market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the bioreactor industry in 2020 owing presence of an increase in the number of biomanufacturing facilities and investments.
Some of the major players operating in the market include BBI-Biotech GmbH, Bioengineering AG, Danaher Corporation, Eppendorf AG, Getinge, Infors HT, Merck KGAA, Sartorius AG, Solaris Biotech Solutions, Thermo Fisher Scientific, Inc.
Global Bioreactor Market Segmentation
Market Insight, by Material Type
• Glass
• Stainless Steel• Single-Use
Market Insight, by Control Type
• Manual• Automated
Market Insight, by Usage
• Lab-scale Production• Pilot Scale Production• Full-Scale Production
Market Insight, by End-User
• R&D Departments & institutes• CROs (Contract Research Organizations)• Biopharmaceutical Companies & Manufacturers• CMOs (Contract Manufacturing Organization)
Market Insight, by Region
Top Company Profiles
• BBI-Biotech GmbH
• Bioengineering AG• Danaher Corporation• Eppendorf AG• Getinge• Infors HT• Merck KGAA• Sartorius AG• Solaris Biotech Solutions• Thermo Fisher Scientific, Inc.
Get a call back
